0000000001062867

AUTHOR

Maria Teresa Ferro

showing 1 related works from this author

Natalizumab Discontinuation after the 24th Course: Which Is Way? The TY-STOP Study

2013

Multiple SclerosisNatalizumab multiple sclerosisNatalizumabSettore MED/26 - NeurologiaMRi
researchProduct